Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Animal testing no longer required for all new drugs approved by FDA

The bill was first introduced by Sens. Rand Paul (R-KY) and Cory Booker (D-NJ) in the Senate, and it was approved unanimously.

Thumbnail

Medicare update designed to help heart failure patients may have the opposite effect

When Medicare made it easier for heart failure patients to receive a LVAD at a hospital that does not perform heart transplants, the change was intended to improve patient access. It turns out, however, that the policy shift could be linked to an unintended consequence. 

Thumbnail

'Reflexive management' of incidental findings causes more harm than good

While there are numerous formulas to help guide providers in managing incidental findings, there is limited data available on the outcomes and cost-effectiveness of the subsequent evaluations that follow.

COVID-19 PHE extended to mid-April

The renewal comes as the country is facing another wave of COVID-19 infections, this time from a new variant identified as XBB.1.5.

cardiologist doctor physician patient black diverse hypertension

Cardiologists push for a more diverse, inclusive healthcare workforce

A recent roundtable discussion focused on how today's healthcare leaders can "begin to dismantle the systems that perpetuate inequities in medicine and build new systems that promote diversity, equity and inclusive excellence."

Mo-99 supplier reaches ‘major milestone’ in non-uranium-based production

Backed with financial support and technical prowess from the U.S. Department of Energy, NorthStar Medical Radioisotopes has shown it can produce, at scale, a critical nuclear imaging radiotracer without using highly enriched uranium.

FDA announces recall of adrenaline lots

Spectrum Laboratory Products is voluntarily recalling the lots after customer complaints found the adrenaline to be discolored.

healthcare value value-based care money dollar

HHS to release first wave of drugs up for price negotiations Sept. 1

HHS is moving forward with drug price negotiations afforded to CMS under the Inflation Reduction Act.